例如:"NBL1", "4681", "drought"
收藏
9308 CD83

9308

CD83

CD83 molecule

protein-coding

Homo sapiens

基因描述

Type Description
Definition CD83 molecule

研究结论

Date Results Publications
2020-12-12 13:22:00 Difference in Presence and Number of CD83(+) Dendritic Cells in Patients with Ulcerative Colitis and Crohn's Disease. 32572123
2020-10-24 13:55:00 Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells. 31293592
2020-07-11 10:05:00 MHC II ubiquitination by E3 ubiquitin-protein ligase MARCH8 (MARCH8) and CD83 antigen (CD83) plays a critical role in T cell thymic selection [Review]. 31063934
2019-07-20 10:14:00 data establish CD83 as a potential biomarker and therapeutic target in Hodgkin lymphoma. 29351987
2019-04-13 11:03:00 Anti-CD83 may be clinically useful in autoimmunity. 29643191

名称对应

Type IDs
Synonymous BL11, HB15
Gene
UniProtKB-ID: CD83_HUMAN, A0A087WX61_HUMAN
UniprotKB: Q01151, A0A087WX61
UniParc: UPI000004C561, UPI0000E09D79
EMBL: AL133259, S53354, Z11697, CR457019, BC030830, AL022396
Ensembl: ENSG00000112149
KO: hsa:9308
Nucleutide sequences
EMBL-CDS: AAB25085.1, CAA77755.1, AAH30830.1, CAG33300.1
Ensembl_TRS: ENST00000379153, ENST00000612003
Protein sequencees
Ensembl_PRO: ENSP00000368450, ENSP00000480760
RefSeq: NP_001035370.1, NP_004224.1, NP_001238830.1
Others
UniRef100: UniRef100_Q01151
UniRef90: UniRef90_Q01151
UniRef50: UniRef50_Q01151
UniGene: Hs.595133
CCDS: CCDS4532.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员